Fresenius stock after-hours at EUR 43.78: minus 0.50 percent
Published on 10/02/2026 at 20:28 | Editorial responsibility: Rafael MĂŒller, Editor-in-Chief AD HOC NEWS
Fresenius stock was at EUR 43.78 after-hours at 8:27 p.m. CEST on October 2, 2026. The price was down 0.50 percent versus the prior close of EUR 44.00 at Lang & Schwarz.
Fresenius stock after-hours
The listed Fresenius SE & Co. KGaA reported on October 1 that it had completed the acquisition of the remaining 45 percent of mAbxience from Insud Pharma and Invim Corporativo. The transaction was signed and completed on September 30, 2026, according to the EQS News.
The consideration is up to EUR 750 million, including a contingent payment of EUR 50 million upon site approvals. Fresenius said the acquisition gives it full ownership of the biosimilars platform within Fresenius Kabiâs Biopharma business and that no change was made to its full-year 2026 guidance. Fresenius Kabi also described the transaction as completing Freseniusâ full ownership of mAbxience.
The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Fresenius stock.
